|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| o-Methylcyclohexanone | CAS 583-60-8 | ||
| CH3C6H9O | RTECS GW1750000 | ||
|
Synonyms & Trade Names 2-Methylcyclohexanone |
DOT ID & Guide 2297 127 |
||
|
Exposure Limits |
NIOSH REL: TWA 50 ppm (230 mg/m3) ST 75 ppm (345 mg/m3) [skin] | ||
| OSHA PEL�: TWA 100 ppm (460 mg/m3) [skin] | |||
| IDLH 600 ppm | Conversion 1 ppm = 4.59 mg/m3 | ||
|
Physical Description Colorless liquid with a weak, peppermint-like odor. |
|||
|
MW: 112.2 |
BP: 325°F |
FRZ: 7°F |
Sol: Insoluble |
|
VP: 1 mmHg |
IP: ? |
|
Sp.Gr: 0.93 |
|
Fl.P: 118°F |
UEL: ? |
LEL: ? |
|
| Class II Combustible Liquid: Fl.P. at or above 100�F and below 140�F. | |||
|
Incompatibilities & Reactivities Strong oxidizers |
|||
|
Measurement Methods NIOSH 2521 |
|
Personal Protection & Sanitation Skin: Prevent skin contact Eyes: Prevent eye contact Wash skin: When contaminated Remove: When wet or contaminated Change: No recommendation |
First Aid (See procedures) Eye: Irrigate immediately Skin: Soap wash promptly Breathing: Respiratory support Swallow: Medical attention immediately |
|
Respirator Recommendations
NIOSH Up to 500 ppm: (APF = 10) Any supplied-air respirator* Up to 600 ppm: (APF = 25) Any supplied-air respirator operated in a continuous-flow mode*/(APF = 50) Any self-contained breathing apparatus with a full facepiece/(APF = 50) Any supplied-air respirator with a full facepiece Emergency or planned entry into unknown concentrations or IDLH conditions: (APF = 10,000) Any self-contained breathing apparatus that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode/(APF = 10,000) Any supplied-air respirator that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode in combination with an auxiliary self-contained positive-pressure breathing apparatus Escape: (APF = 50) Any air-purifying, full-facepiece respirator (gas mask) with a chin-style, front- or back-mounted organic vapor canister/Any appropriate escape-type, self-contained breathing apparatus |
|
| Exposure Routes inhalation, skin absorption, ingestion, skin and/or eye contact | |
| Symptoms In animals: irritation eyes, mucous membrane; narcosis; dermatitis | |
|
Target Organs
Skin, respiratory system, liver, kidneys, central nervous system |
|
| See also: INTRODUCTION |